Global Fund Leadership Shortlist Unveiled Amid Donor Friction And Push For Reform - Health Policy Watch
This story deserves to be shared
Send it to someone who'd care, or post it on your networks.
This article is an excerpt. To read the full content, visit the original source. Health Policy Watch
Related articles
Rare double living donor saves two strangers in Alberta - Alberta Health Services
The Giller Prize Presents its 2026 Shortlist - Giller Prize
THE PRIZEImportant DatesSubmission GuidelinesJuryPast WinnersAll Nominees (1994-2025)Board of DirectorsWriters’ CircleOur SupportersOur PartnersMedia ResourcesBETWEEN THE PAGESSCHOLARSHIPEN ApplicationFR ApplicationBOOK CLUBSGiller Book Club#BookTalkCRAVING CANLIT2026202520242023202220212020CONTACTNewsletter Sign-UpBLOG & NEWSDONATE Published On: October 5th, 2026October 5, 2026 (Toronto, ON) – Five formidable Canadian novels have been named to the 2026 Giller Prize shortlist. Representing five publishing imprints, four provinces, and three national bestsellers, these authors stand as a stirring testament to the fearlessness, ingenuity, and revolutionary power of Canadian storytellers as the prize celebrates its 33rd year as the country’s premier fiction award.
Continuous glucose monitors help type 2 diabetes patients spend 5 more hours a day in healthy blood sugar range - Medical Xpress
Continuous glucose monitors (CGMs) could transform diabetes management for millions of Americans with type 2 diabetes who don't take insulin, according to findings published in the New England Journal of Medicine. The clinical trial found that adults using CGMs spent approximately five additional hours each day within their target blood sugar range compared with those receiving routine care. Nearly twice as many CGM users also achieved an A1c level below 7%, a common treatment goal for people with diabetes.
Wearing headphones during surgery may reduce nausea and vomiting afterward - Medical Xpress
Patients who wore noise-canceling headphones during minimally invasive gynecological surgery were significantly less likely to experience postoperative nausea and vomiting (PONV), suggest findings from a randomized clinical trial presented at the Anesthesiology 2026 annual meeting.
Kefah Mokbel: Can Whole-Genome Sequencing-Based ctDNA Monitoring Help Personalize Adjuvant Treatment? - Oncodaily
“Beyond Detecting Cancer Recurrence: Can Whole-Genome Sequencing-Based ctDNA Monitoring Help Personalize Adjuvant Treatment? An exciting new study published in The Oncologist highlights the clinical potential of Signatera Genome, a whole-genome sequencing (WGS)-based, tumor-informed circulating tumor DNA (ctDNA) assay, not only for detecting molecular residual disease (MRD), but also for potentially informing adjuvant treatment decisions.
0 comments
No comments yet. Be the first to share your thoughts!